Icotrokinra vs Tesamorelin
Overview
Icotrokinra is primarily a immune support peptide, while Tesamorelin is used for performance & growth.
This page compares Icotrokinra and Tesamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | Tesamorelin | |
|---|---|---|
| Category | Immune Support | Performance & Growth |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | — | 2 mg |
| Frequency | — | daily |
| Reported benefits | — | Visceral fat reduction, improved body composition, GH release |
| Reported side effects | — | Joint pain, peripheral edema |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while Tesamorelin falls under Performance & Growth. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Icotrokinra: FDA-approved. Tesamorelin: FDA-approved.
Dosing. Typical dosing for Icotrokinra is not catalogued. Tesamorelin is typically dosed at 2 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and Tesamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and Tesamorelin?
- Icotrokinra is primarily a immune support peptide, while Tesamorelin is used for performance & growth. Icotrokinra is FDA-approved for one or more indications, whereas Tesamorelin is FDA-approved for one or more indications.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is Tesamorelin used for?
- GHRH for visceral fat.
- Can you take Icotrokinra and Tesamorelin together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and Tesamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or Tesamorelin FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. Tesamorelin is FDA-approved for one or more indications.
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- Tesamorelin — full monograph: mechanism, research, dosing & references